Age of the Donor Reduces the Ability of Human Adipose-Derived Stem Cells to Alleviate Symptoms in the Experimental Autoimmune Encephalomyelitis Mouse Model

There is a significant clinical need for effective therapies for primary progressive multiple sclerosis, which presents later in life (i.e., older than 50 years) and has symptoms that increase in severity without remission. With autologous mesenchymal stem cell therapy now in the early phases of cli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Scruggs, Brittni A., Semon, Julie A., Zhang, Xiujuan, Zhang, Shijia, Bowles, Annie C., Pandey, Amitabh C., Imhof, Kathleen M.P., Kalueff, Allan V., Gimble, Jeffrey M., Bunnell, Bruce A.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2013
Assuntos:
Tissue Engineering and Regenerative Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3785264/
https://ncbi.nlm.nih.gov/pubmed/24018793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2013-0026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados